Gotowa bibliografia na temat „Maladie thrombo-Embolique”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Maladie thrombo-Embolique”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Maladie thrombo-Embolique"
Wagner, T. "Maladie thrombo-embolique veineuse". Revue des Maladies Respiratoires 25, nr 2 (luty 2008): 27. http://dx.doi.org/10.1016/s0761-8425(08)74821-6.
Pełny tekst źródłaTromeur, C. "Maladie veineuse thrombo-embolique". Revue des Maladies Respiratoires Actualités 4, nr 7 (grudzień 2012): 725–32. http://dx.doi.org/10.1016/s1877-1203(12)70341-5.
Pełny tekst źródłaLorut, C., G. Meyer, C. Leroyer i F. Parent. "La maladie thrombo-embolique veineuse". Revue des Maladies Respiratoires 22, nr 1 (luty 2005): 169–73. http://dx.doi.org/10.1016/s0761-8425(05)85452-x.
Pełny tekst źródłaDanchin, N. "La maladie veineuse thrombo-embolique". Annales de Cardiologie et d'Angéiologie 51, nr 3 (2002): 123. http://dx.doi.org/10.1016/s0003-3928(02)00082-3.
Pełny tekst źródłaÉmile, Carole. "Grossesse et maladie thrombo-embolique veineuse". Option/Bio 32, nr 629-630 (marzec 2021): 26–28. http://dx.doi.org/10.1016/s0992-5945(21)00051-9.
Pełny tekst źródłaJahnaoui, N., S. Hammi, I. Id Ahmed, K. Marc, M. Soualhi, R. Zahraoui, J. Benamor, J. E. Bourkadi i G. Iraqi. "Tuberculose pulmonaire et maladie thrombo-embolique". Revue des Maladies Respiratoires 29 (styczeń 2012): A112. http://dx.doi.org/10.1016/j.rmr.2011.10.370.
Pełny tekst źródłaMeyer, G. "Maladie veineuse thrombo-embolique et cancer". Journal des Maladies Vasculaires 36 (grudzień 2011): S42—S47. http://dx.doi.org/10.1016/s0398-0499(11)70008-7.
Pełny tekst źródłaHorellou, M. H., G. Plu-Bureau i J. Lepercq. "Maladie thrombo-embolique veineuse et grossesse". La Revue de Médecine Interne 36, nr 3 (marzec 2015): 219–24. http://dx.doi.org/10.1016/j.revmed.2014.10.356.
Pełny tekst źródłaSgard, B. "Maladie veineuse thrombo-embolique – Session 2". Médecine Nucléaire 41, nr 5 (wrzesień 2017): 349–52. http://dx.doi.org/10.1016/j.mednuc.2017.07.004.
Pełny tekst źródłaCombe, S., i H. R. Büller. "Nouveaux traitements de la maladie thrombo-embolique veineuse". Journal des Maladies Vasculaires 36 (grudzień 2011): S16—S19. http://dx.doi.org/10.1016/s0398-0499(11)70003-8.
Pełny tekst źródłaRozprawy doktorskie na temat "Maladie thrombo-Embolique"
Couturaud, Francis. "Risque de maladie thrombo-embolique veineuse chez les membres de familles au premier degré de patients ayant une maladie thrombo-embolique veineuse idiopathique". Lyon 1, 2006. http://www.theses.fr/2006LYO10184.
Pełny tekst źródłaRational : In patients with idiopathic venous thromboembolism (VTE), the risk of recurrent VTE is high and a large proportion of these patients carry inherited thrombophilia. Our hypothesis is that patients with idiopathic VTE without detectable inherited thrombophilia have a genetic prothrombotic state not yet discovered. Objective : To evaluate the risk of VTE in first degree relatives of patients with idiopathic VTE and with or without inherited thrombophilia. If our hypothesis is true, this risk should be similar, with or without thrombophilia. Methods : In this international multicentre study, 1778 first degree relatives of 348 propositus with objectively diagnosed idiopathic VTE were included. Relatives were classified as having “certain VTE”, “uncertain VTE” or “no VTE” according to a predefined and standardised questionnaire. All the propositus were tested for the Leiden mutation and the G20210A prothrombin gene mutation. Results : In multivariate analysis, when “uncertain VTE” were classified as “No VTE”, we observed a trend of an increased risk of VTE in first degree relatives of probants with an inherited thrombophilia (relative risk of 1,52 [0,98 – 2,37], p = 0,06); when “uncertain VTE” were classified as “certain VTE”, the relative risk of VTE was closed to 1. 0 (1,18 [0,87-1,60], p = 0,3). For each level of VTE diagnosis criteria precision, there was an increased risk of VTE in first degree relatives women and in relatives from younger probants. Conclusion : The presence of an inherited thrombophilia in patients with idiopathic VTE is weakly associated with an increased risk in their first degree relatives. This observation supports our scientific hypothesis. One the main implications of this study is that the prevention of VTE should not be proposed in only first degree relatives of patients with VTE and inherited thrombophilia
Yvorra, Serge. "La maladie veineuse thrombo-embolique ambulatoire : donnees epidemiologiques, etiologiques, et suivi". Aix-Marseille 2, 1992. http://www.theses.fr/1992AIX20856.
Pełny tekst źródłaPérol, Maurice. "Maladie thrombo-embolique pulmonaire chronique, éléments du pronostic : à propos de 27 observations". Lyon 1, 1989. http://www.theses.fr/1989LYO1M360.
Pełny tekst źródłaRiemens, Paul. "La maladie thrombo-embolique et son coût : considérations générales et en long séjour". Bordeaux 2, 1990. http://www.theses.fr/1990BOR25281.
Pełny tekst źródłaChalayer, Emilie. "Myélome multiple et maladie thrombo-embolique veineuse : aspects épidémiologiques, économiques, physiopathologiques et pharmacologiques". Thesis, Saint-Etienne, 2015. http://www.theses.fr/2015STET007T/document.
Pełny tekst źródłaThe association between multiple myeloma and venous thromboembolic disease is well established. This incidence in myeloma is on average from 10 to 20%. It appears to be higher in newly diagnosed myeloma and immunomodulatory drugs such as thalidomide might significantly increase the risk. However, the risk of thrombosis due to these treatments is not yet well defined. First, we performed a review of these diseases in order to delimit the field of this study through a literature review. Then, we evaluated the incidence of venous thromboembolic disease in patients with myeloma and treated with immunomodulatory, identified the thrombotic risk factors and evaluated the thrombotic risk assessment based on the physicians choice, through an observational, multicenter, prospective French study. Moreover, we performed the medico-economic analysis of the only randomized trial conducted to date on the thrombophylaxis in patients with multiple myeloma treated with thalidomide in the first line of chemotherapy. This analysis showed a gain in quality of life associated with significant cost savings in the prevention of thrombosis by aspirin rather than heparin. Finally we performed two medical studies using thrombin generation test, a global assay that measures the overall tendency of a plasma sample to form thrombin. The first study was conducted to predict patients who will have thrombosis. The second is performed to know if a heparin resistance with the usual doses in this pathology, exists
Lanoy, Léonard Fisch Alain. "Maladie veineuse thrombo-embolique et voyage aérien de courte durée réalités et perspectives /". Créteil : Université de Paris-Val-de-Marne, 2009. http://doxa.scd.univ-paris12.fr:80/theses/th0512111.pdf.
Pełny tekst źródłaSCHAMBRI, YVES. "Maladie thrombo-embolique : quel bilan etiologique ? l'experience du chg de pamiers : 40 cas". Toulouse 3, 1989. http://www.theses.fr/1989TOU31107.
Pełny tekst źródłaBREHM, GAILHARD SYLVIE, i FRANCOIS GALLEGO. "Le risque thrombo-embolique chez le sujet age hospitalise : consequences sur l'utilisation des anticoagulants". Toulouse 3, 1988. http://www.theses.fr/1988TOU31194.
Pełny tekst źródłaDESCHLER, SERGE. "L'heparinotherapie dans la prevention de la maladie thrombo-embolique en traumatologie et en orthopedie". Strasbourg 1, 1987. http://www.theses.fr/1987STR10680.
Pełny tekst źródłaLAPEYRE, FRANCOIS. "Filtres caves percutanes et maladie thrombo-embolique : indications et resultats ; revue de 180 observations". Toulouse 3, 1989. http://www.theses.fr/1989TOU31096.
Pełny tekst źródłaCzęści książek na temat "Maladie thrombo-Embolique"
Vernhet Kovacsik, H. "Embolie pulmonaire et maladie thrombo-embolique". W Collection de la Société française d’imagerie cardiaque et vasculaire, 207–20. Paris: Springer Paris, 2009. http://dx.doi.org/10.1007/978-2-287-99166-0_17.
Pełny tekst źródłaPlu-Bureau, G. "Contraception et maladie veineuse thrombo-embolique". W La Contraception en Pratique, 41–46. Elsevier, 2013. http://dx.doi.org/10.1016/b978-2-294-72785-6.00007-4.
Pełny tekst źródłaAya, G., D. Benhamou, F. Bolandard, M. Bonnin, E. Boselli, F. Broisin, B. Bryssine i in. "Maladie thrombo-embolique veineuse en post-partum". W Protocoles en anesthésie et analgésie obstétricales, 121–25. Elsevier, 2010. http://dx.doi.org/10.1016/b978-2-294-71053-7.00045-7.
Pełny tekst źródłaAya, G., F. Bayoumeu, D. Benhamou, F. Bolandard, M. P. Bonnet, M. Bonnin, E. Boselli i in. "Maladie thrombo-embolique veineuse en post-partum". W Protocoles en Anesthésie et Analgésie Obstétricales, 175–79. Elsevier, 2018. http://dx.doi.org/10.1016/b978-2-294-76011-2.00056-7.
Pełny tekst źródłaCohen, Ariel, Emmanuelle Berthelot-Garcias i Fanny Douna. "Examens diagnostiques dans la maladie veineuse thrombo-embolique". W Urgences cardio-vasculaires et situations critiques en cardiologie, 61–65. Elsevier, 2010. http://dx.doi.org/10.1016/b978-2-294-71196-1.50017-0.
Pełny tekst źródłaCohen, Ariel, Emmanuelle Berthelot-Garcias i Fanny Douna. "Procédure interventionnelle dans la maladie veineuse thrombo-embolique". W Urgences cardio-vasculaires et situations critiques en cardiologie, 141. Elsevier, 2010. http://dx.doi.org/10.1016/b978-2-294-71196-1.50032-7.
Pełny tekst źródła